Literature DB >> 20584206

Mechanisms of hypokalemia-induced ventricular arrhythmogenicity.

Oleg E Osadchii1.   

Abstract

Hypokalemia is a common biochemical finding in cardiac patients and may represent a side effect of diuretic therapy or result from endogenous activation of renin-angiotensin system and high adrenergic tone. Hypokalemia is independent risk factor contributing to reduced survival of cardiac patients and increased incidence of arrhythmic death. Animal studies demonstrate that hypokalemia-induced arrhythmogenicity is attributed to prolonged ventricular repolarization, slowed conduction, and abnormal pacemaker activity. The prolongation of ventricular repolarization in hypokalemic setting is caused by inhibition of outward potassium currents and often associated with increased propensity for early afterdepolarizations. Slowed conduction is attributed to membrane hyperpolarization and increased excitation threshold. Abnormal pacemaker activity is attributed to increased slope of diastolic depolarization in Purkinje fibers, as well as delayed afterdepolarizations caused by Ca2+ overload secondary to inhibition of Na+--K+ pump and stimulation of the reverse mode of the Na+--Ca2+ exchange. Hypokalemia effect on repolarization is not uniform at distinct ventricular sites thereby contributing to amplified spatial repolarization gradients which promote unidirectional conduction block. In hypokalemic heart preparations, the prolongation of action potential may be associated with shortening of effective refractory period, thus increasing the propensity for ventricular re-excitation over late phase of repolarization. Shortened refractoriness and slowed conduction contribute to reduced excitation wavelength thereby facilitating re-entry. The interplay of triggering factors (early and delayed afterdepolarizations, oscillatory prepotentials in Purkinje fibers) and a favorable electrophysiological substrate (unidirectional conduction block, reduced excitation wavelength, increased critical interval for ventricular re-excitation) may account for the mechanism of life-threatening tachyarrhythmias in hypokalemic patients.
© 2010 The Author Fundamental and Clinical Pharmacology © 2010 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Mesh:

Year:  2010        PMID: 20584206     DOI: 10.1111/j.1472-8206.2010.00835.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  47 in total

1.  Hypokalemia and sudden cardiac death.

Authors:  Keld Kjeldsen
Journal:  Exp Clin Cardiol       Date:  2010

2.  Arrhythmogenic consequences of myofibroblast-myocyte coupling.

Authors:  Thao P Nguyen; Yuanfang Xie; Alan Garfinkel; Zhilin Qu; James N Weiss
Journal:  Cardiovasc Res       Date:  2011-11-02       Impact factor: 10.787

3.  Enhanced sensitivity of aged fibrotic hearts to angiotensin II- and hypokalemia-induced early afterdepolarization-mediated ventricular arrhythmias.

Authors:  Aneesh Bapat; Thao P Nguyen; Jong-Hwan Lee; Ali A Sovari; Michael C Fishbein; James N Weiss; Hrayr S Karagueuzian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

Review 4.  Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.

Authors:  Swaminathan P Iyer; Francine F Foss
Journal:  Oncologist       Date:  2015-06-22

5.  Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel.

Authors:  Anne M Noonan; Robin A Eisch; David J Liewehr; Tristan M Sissung; David J Venzon; Thomas P Flagg; Mark C Haigney; Seth M Steinberg; William D Figg; Richard L Piekarz; Susan E Bates
Journal:  Clin Cancer Res       Date:  2013-04-15       Impact factor: 12.531

6.  A physiologic-based approach to the treatment of a patient with hypokalemia.

Authors:  Abdo Asmar; Rajesh Mohandas; Charles S Wingo
Journal:  Am J Kidney Dis       Date:  2012-09       Impact factor: 8.860

Review 7.  ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.

Authors:  Angela Yee Moon Wang; K Scott Brimble; Gillian Brunier; Stephen G Holt; Vivekanand Jha; David W Johnson; Shin-Wook Kang; Jeroen P Kooman; Mark Lambie; Chris McIntyre; Rajnish Mehrotra; Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2015 Jul-Aug       Impact factor: 1.756

8.  Arrhythmia Protection in Hypokalemia: A Novel Role of Ca2+-Activated K+ Currents in the Ventricle.

Authors:  Michela Faggioni; Björn C Knollmann
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690

9.  Small-Conductance Calcium-Activated Potassium Current Is Activated During Hypokalemia and Masks Short-Term Cardiac Memory Induced by Ventricular Pacing.

Authors:  Yi-Hsin Chan; Wei-Chung Tsai; Jum-Suk Ko; Dechun Yin; Po-Cheng Chang; Michael Rubart; James N Weiss; Thomas H Everett; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690

10.  Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.

Authors:  Arash Pezhouman; Neha Singh; Zhen Song; Michael Nivala; Anahita Eskandari; Hong Cao; Aneesh Bapat; Christopher Y Ko; Thao Nguyen; Zhilin Qu; Hrayr S Karagueuzian; James N Weiss
Journal:  Circulation       Date:  2015-08-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.